Market revenue in 2024 | USD 44.9 million |
Market revenue in 2030 | USD 84.9 million |
Growth rate | 11.4% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 81.29% in 2024. Horizon Databook has segmented the Brazil deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, presence of hospitals with well established infrastructure in Brazil attracts patients from other countries for treatment of various neurological diseases. Moreover, owing to rising incidence of epilepsy & PD and lack of awareness about their treatment, various government organizations are organizing awareness programs.
For instance, in November 2017, the Brazilian Association of Epilepsy (ABE) launched a new program to increase awareness about epilepsy among children. Thus, increasing awareness coupled with rising prevalence of neurological diseases is expected to boost the adoption of deep brain stimulation devices in the country.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account